We are live on ! Find out more
LOM

Loeb Offshore Management Portfolio holdings

AUM $547M
1-Year Est. Return 50.11%
This Fund
S&P 500
This Quarter Est. Return
+16.52%
1 Year Est. Return
+50.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$362M
AUM Growth
+$38.1M
Cap. Flow
+$29.5M
Cap. Flow %
8.14%
Top 10 Hldgs %
28.79%
Holding
336
New
103
Increased
46
Reduced
36
Closed
148

Sector Composition

Rank Sector Weight
1 Communication Services 26.41%
2 Technology 10.38%
3 Healthcare 8.47%
4 Consumer Discretionary 7.85%
5 Real Estate 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
126
Pfizer
PFE
$144B
$450K 0.12%
15,479
+3,445
+29% +$100K
AGN
127
DELISTED
Allergan plc
AGN
$430K 0.12%
2,559
-30,352
-92% -$4.74M
COV
128
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$430K 0.12%
6,313
-1,071
-15% -$69.7K
BDSI
129
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$428K 0.12%
72,624
-87,956
-55% -$453K
BMY icon
130
Bristol-Myers Squibb
BMY
$130B
$426K 0.12%
+8,009
New +$408K
OCR
131
DELISTED
OMNICARE INC
OCR
$425K 0.12%
7,043
+2,826
+67% +$162K
ESRX
132
DELISTED
Express Scripts Holding Company
ESRX
$417K 0.12%
5,938
-766
-11% -$50K
CI icon
133
Cigna
CI
$79.6B
$407K 0.11%
4,657
-553
-11% -$45.2K
HK
134
DELISTED
Halcon Resources Corporation
HK
$407K 0.11%
+612
New +$475K
DHR icon
135
Danaher
DHR
$140B
$399K 0.11%
+7,691
New +$378K
TBOW
136
DELISTED
TRUNKBOW INTL HLDGS LTD COM
TBOW
$397K 0.11%
+300,490
New +$351K
CVS icon
137
CVS Health
CVS
$140B
$394K 0.11%
+5,502
New +$354K
VRTX icon
138
Vertex Pharmaceuticals
VRTX
$124B
$394K 0.11%
5,302
+1,619
+44% +$113K
CAH icon
139
Cardinal Health
CAH
$54.5B
$390K 0.11%
5,844
-425
-7% -$26K
BKD icon
140
Brookdale Senior Living
BKD
$3.67B
$350K 0.1%
12,887
+2,591
+25% +$71.8K
WMGI
141
DELISTED
Wright Medical Group Inc
WMGI
$350K 0.1%
+11,401
New +$323K
DRCO
142
DELISTED
DYNAMICS RESEARCH CORP
DRCO
$345K 0.1%
+30,033
New +$231K
RPRX
143
DELISTED
Repros Therapeutics Inc.
RPRX
$342K 0.09%
+18,688
New +$353K
REGN icon
144
Regeneron Pharmaceuticals
REGN
$72.9B
$327K 0.09%
1,187
+342
+40% +$98.4K
WBCO
145
DELISTED
WASHINGTON BANKING CO
WBCO
$327K 0.09%
+18,451
New +$306K
CBST
146
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$322K 0.09%
4,673
+1,040
+29% +$67.3K
FURX
147
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$322K 0.09%
7,669
+3,008
+65% +$124K
NKTR icon
148
Nektar Therapeutics
NKTR
$2.39B
$320K 0.09%
+1,877
New +$303K
FRX
149
DELISTED
FOREST LABORATORIES INC
FRX
$316K 0.09%
+5,262
New +$265K
THC icon
150
Tenet Healthcare
THC
$22.6B
$306K 0.08%
7,269
-15,616
-68% -$680K

Similar funds

Loeb Offshore Management's Q4 2013 Portfolio in Review

As of Q4 2013, Loeb Offshore Management held 336 positions worth $362M, up 12% from $324M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Loeb Offshore Management deployed $29.5M of net new capital in Q4 2013, opening 103 new positions and adding to 46 existing holdings. Its largest new stake was TIME WARNER CABLE INC NEW COM STK: 254,354 shares worth $34.5M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, up from 8.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Allergan plc, an estimated $4.74M trimmed.

  • Loeb Offshore Management's largest Q4 2013 buy was TIME WARNER CABLE INC NEW COM STK: 254,354 shares worth $34.5M.
  • Loeb Offshore Management added most to BROOKFIELD OFFICE PROPERTIES. INC in Q4 2013, an estimated $6.28M increase.
  • Loeb Offshore Management's biggest Q4 2013 reduction was Allergan plc, cutting an estimated $4.74M.
  • Loeb Offshore Management fully exited MetLife in Q4 2013, selling an estimated $9.45M.
  • Loeb Offshore Management's ten largest holdings make up 29% of its $362M portfolio in Q4 2013.
  • Loeb Offshore Management opened 103 new positions and closed 148 in Q4 2013.
  • Loeb Offshore Management's portfolio value rose 12% quarter-over-quarter to $362M.

Based on Loeb Offshore Management's 13F filing for Q4 2013, filed 14 Feb 2014.